Next Generation Sequencing (NGS) Market – Trends Forecast Till 2031

1
Next Generation Sequencing (NGS) Market Trends
Forecast Till 2031
sales_at_delvens.com www.delvens.com
2

Next Generation Sequencing (NGS) Market, By
Technology (Targeted Sequencing Resequencing),
By Product, By Application, By Workflow, By
End-use and region (North America, Europe,
Asia-Pacific, Middle East and Africa and South
America).

Request For Free Sample Report
https//www.delvens.com/get-free-sample/next-gener
ation-sequencing-ngs-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
The global Next Generation Sequencing (NGS)
Market size was estimated at USD 12,990 million
in 2024 and is projected to reach USD 31,910.4
million in 2031 at a CAGR of 13.7 during the
forecast period 2025-2031. Next
Generation Sequencing (NGS) refers to a set of
advanced technologies that allow for rapid and
high-throughput sequencing of DNA and RNA,
enabling researchers to decode genetic material
more efficiently and cost-effectively than
traditional methods. NGS encompasses various
techniques that facilitate deep sequencing, such
as whole genome sequencing, exome sequencing, and
transcriptome sequencing, allowing for detailed
analyses of genetic variations, mutations, and
gene expression profiles. This technology has
revolutionized genomic research, clinical
diagnostics, and personalized medicine, offering
a powerful tool for understanding complex
biological processes and diseases. Purchase
this Report https//www.delvens.com/checkout/next
-generation-sequencing-ngs-market
sales_at_delvens.com
www.delvens.com
4
Key Findings
The Next Generation Sequencing (NGS) Market is
segmented into various segments such as
Technology, Product, Application, Workflow,
End-use and Region. The targeted sequencing and
resequencing technology segment is growing in
tandem with the broader expansion of whole genome
sequencing (WGS). As WGS generates vast amounts
of data, there is a corresponding need for
targeted analysis of specific genes and genetic
expressions. The consumables segment leads the
market, driven by the recurrent demand for
consumables in both commercial and research
applications of NGS. These consumables, including
sample preparation kits and target enrichment
kits, are vital for various diagnostic and
research purposes, such as cancer research and
genomic sequencing. In the application space,
the oncology segment stands out due to the
increasing need for advanced technologies to
study cancer and tumor dynamics. The use of NGS
in cancer research, particularly for DNA and RNA
sequencing, epigenetics, and chromosomal
abnormalities, is accelerating the growth of this
segment.
sales_at_delvens.com
www.delvens.com
5
Key Findings
The market is also divided into various regions
such as North America, Europe, Asia-Pacific,
South America, and Middle East and Africa. North
America is estimated to account for the largest
market share during the forecast period. Inquire
Before Buying https//www.delvens.com/Inquire-bef
ore-buying/next-generation-sequencing-ngs-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• Illumina
• F. Hoffman-La Roche Ltd.
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Oxford Nanopore Technologies
• PierianDx
• Genomatix GmbH
• DNASTAR, Inc.
• Perkin Elmer, Inc.
• Eurofins GATC Biotech GmbH
• BGI.

sales_at_delvens.com
www.delvens.com
7
Recent Developments
In May 2024, Oxford Nanopore Technologies
partnered with Twist Bioscience to introduce a
new Pharmacogenomics Beta Programme. This
long-read pharmacogenomics solution, intended for
research use, aims to deliver clear genetic
results through a streamlined, end-to-end
workflow, from sample preparation to
pharmacogenomics star allele calling. In
September 2023, PacBio unveiled a collaboration
with Hamilton, Integra, Revvity, and Tecan to
develop fully automated protocols for preparing
samples to be sequenced on the Revio and Sequel
II and IIe systems.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com